Carcinogenesis, Vol. 20, No. 2, 221-227,
February 1999
© 1999 Oxford University Press
Resistance to mammary tumorigenesis in Copenhagen rats is associated with the loss of preneoplastic lesions
1 Departments of Medical Biophysics and
2 Nutritional Sciences, Faculty of Medicine, University of Toronto, 150 College Street, Toronto M5S 3E2, Canada
The resistance of Copenhagen (Cop) rats to mammary tumor development has recently been linked to three loci, but the genes have yet to be cloned and the mechanism of resistance is still largely unknown. In order to determine the cellular events associated with resistance, we prepared mammary whole mounts from Cop and susceptible Wistar Furth (WF) rats 0, 15, 30, 45 and 60 days after treatment with 50 mg/kg N-methyl-N-nitrosourea (MNU). At 15 days, treated rats of both strains had significantly more undifferentiated structures [terminal end buds (TEBs)] and significantly fewer differentiated structures [alveolar buds (ABs)] than untreated rats. Treated Cop rats, however, had significantly more TEBs and fewer ABs than age-matched, treated WF rats. Histological analysis of preneoplastic lesions tentatively identified from the whole mounts showed that like WF rats, Cop rats developed early preneoplastic lesions [intraductal proliferations (IDPs)] by 15 days post-MNU treatment. Unlike IDPs from WF rats, however, the IDPs in Cop rats then decreased in number until they were absent 60 days post-MNU treatment. Furthermore, they failed to progress into more advanced lesions such as ductal carcinomas in situ (DCIS). Finally, we found G
A activating mutations in codon 12 of the Ha-ras gene in 60% of IDPs from Cop rats and 75% of IDPs from WF rats. Our results show that resistance in Cop rats is not due to a target cell population for the carcinogen that is smaller than in susceptible rats or to the failure of the carcinogen to inhibit mammary gland differentiation. Furthermore, we have shown that Cop rats develop preneoplastic IDPs that harbor Ha-ras mutations but, unlike IDPs in susceptible strains, they fail to progress and ultimately disappear.
Abbreviations: ABs, alveolar buds; Cop, Copenhagen; DAH, ductal alveolar hyperplasia; DCIS, ductal carcinoma in situ; DH, ductal hyperplasia; DMBA, 7,12-dimethylbenz[a]anthracene; H & E, hematoxylin and eosin; HANs, hyperplastic alveolar nodules; IDPs, intraductal proliferations; mcs, mammary carcinoma suppressor; MNU, N-methyl-N-nitrosourea; PBS, phosphatebuffered saline; PCR, polymerase chain reaction; SD, Sprague–Dawley; TEBs, terminal end buds; WF, Wistar Furth.
3 To whom correspondence should be addressed Email: m.archer{at}utoronto.ca
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Xuan, Y.-J. Li, G. Liu, Y. Ben-David, and M. C. Archer Interleukin-24 Induces Expression of {beta}4 Integrin but Suppresses Anchorage-Independent Growth of Rat Mammary Tumor Cells by a Mechanism That Is Independent of {beta}4 Mol. Cancer Res., March 1, 2009; 7(3): 433 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Chan, X. Lu, F. M. Merchant, J.D. Iglehart, and P. L. Miron Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer Carcinogenesis, August 1, 2005; 26(8): 1343 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Maffini, A. M. Soto, J. M. Calabro, A. A. Ucci, and C. Sonnenschein The stroma as a crucial target in rat mammary gland carcinogenesis J. Cell Sci., March 15, 2004; 117(8): 1495 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Quan and S.-J. Lu Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays Carcinogenesis, October 1, 2003; 24(10): 1593 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yu and E. G. Snyderwine H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary gland cancer Carcinogenesis, December 1, 2002; 23(12): 2123 - 2128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Wood, J. E. Korkola, and M. C. Archer Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes Carcinogenesis, January 1, 2002; 23(1): 1 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Shull, K. L. Pennington, T. M. Reindl, M. C. Snyder, T. E. Strecker, T. J. Spady, M. Tochacek, and R. D. McComb Susceptibility to Estrogen-Induced Mammary Cancer Segregates as an Incompletely Dominant Phenotype in Reciprocal Crosses between the ACI and Copenhagen Rat Strains Endocrinology, December 1, 2001; 142(12): 5124 - 5130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kindler-Röhrborn, A. B. Kind, B. U. Koelsch, C. Fischer, and M. F. Rajewsky Suppression of Ethylnitrosourea-induced Schwannoma Development Involves Elimination of neu/erbB-2 Mutant Premalignant Cells in the Resistant BDIV Rat Strain Cancer Res., September 1, 2000; 60(17): 4756 - 4760. [Abstract] [Full Text]
|
|
|
|
|
|
A. Shilkaitis, A. Green, V. Steele, R. Lubet, G. Kelloff, and K. Christov Neoplastic transformation of mammary epithelial cells in rats is associated with decreased apoptotic cell death Carcinogenesis, February 1, 2000; 21(2): 227 - 233. [Abstract] [Full Text] [PDF]
|
|